Tornier Perform Reversed Glenoid
Device Bone Substitute
PDI 00846832088447
General payments
$3,567,290
Research payments
$291,080
Through program year 2025, $3,567,290 in general payments and $291,080 in research payments were reported against Tornier Perform Reversed Glenoid (Bone Substitute).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,354,792 | 1,039 |
| 2025 | Research | $55,097 | 9 |
| 2024 | General | $1,417,383 | 843 |
| 2024 | Research | $87,032 | 9 |
| 2023 | General | $665,110 | 452 |
| 2023 | Research | $132,116 | 14 |
| 2022 | General | $130,006 | 125 |
| 2022 | Research | $16,835 | 2 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 22 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 40 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
2,459 general · 34 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.